Compounds > miltefosine

miltefosine and 8-aminoquinoline

miltefosine has been researched along with 8-aminoquinoline in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sherwood, JA1
Sundar, S1
Boelaert, M; Bryceson, AD; Croft, SL; Desjeux, P; Guerin, PJ; Olliaro, P; Sundar, S; Wasunna, MK1
Dwivedi, S; Koirala, S; Rijal, S; Sangraula, H; Sharma, KK1
Berman, J1
Bonnet-Delpon, D; Bories, C; Chollet, C; Crousse, B; Loiseau, PM1
Castanys, S; Castanys-Muñoz, E; Gamarro, F; Pérez-Victoria, JM1
Bavchvarov, BI; Campillo, M; Castanys, S; Gamarro, F; López-Martín, C; Martínez-García, M; Pérez-Victoria, JM; Torrecillas, IR1
Kumar, M; Singh, N; Singh, RK1
Gomes, MS; Gomes, P; Matos, J; Moreira, R; Tomás, A; Vale, N; Vale-Costa, S1
Mesquita, JT; Reimão, JQ; Tempone, AG1

Reviews

4 review(s) available for miltefosine and 8-aminoquinoline

ArticleYear
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:8

    Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Asia, Western; Brazil; Developing Countries; Dogs; Female; Humans; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Sudan

2002
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    The Journal of the Association of Physicians of India, 2003, Volume: 51

    Topics: Administration, Oral; Aminoquinolines; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Phosphorylcholine

2003
Clinical status of agents being developed for leishmaniasis.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11

    Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine

2005
Leishmaniasis: current status of available drugs and new potential drug targets.
    Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:6

    Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors

2012

Other Studies

7 other study(ies) available for miltefosine and 8-aminoquinoline

ArticleYear
Miltefosine for visceral leishmaniasis.
    The New England journal of medicine, 2000, Mar-23, Volume: 342, Issue:12

    Topics: Administration, Oral; Aminoquinolines; Antiprotozoal Agents; Drug Synergism; Humans; Leishmaniasis, Visceral; Phosphorylcholine

2000
Drug resistance in Indian visceral leishmaniasis.
    Tropical medicine & international health : TM & IH, 2001, Volume: 6, Issue:11

    Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome

2001
In vitro antileishmanial activity of fluoro-artemisinin derivatives against Leishmania donovani.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:7

    Topics: Aminoquinolines; Animals; Antiparasitic Agents; Artemisinins; Drug Resistance; Erythrocytes; Indicators and Reagents; Leishmania donovani; Macrophages; Phosphorylcholine

2008
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aminoquinolines; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Base Sequence; Biological Transport, Active; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genes, Protozoan; Humans; Leishmania infantum; Leishmaniasis, Visceral; Lipid Bilayers; Phosphorylcholine; Protozoan Proteins; Recombinant Proteins; Transformation, Genetic

2008
Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Aminoquinolines; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Bacterial; Ketoconazole; Leishmania tropica; Leishmaniasis; Phosphorylcholine; Protein Binding

2011
Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Cell Culture Techniques; Cell Survival; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Peptidomimetics; Phosphorylcholine; Primaquine

2012
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
    Acta tropica, 2014, Volume: 130

    Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles

2014